Aug 2018: New investors come onboard

Updated: Jan 8, 2020

LIQID Medical is pleased to welcome two new VC investors in preparation for the OptiShunt First-in-Man clinical trials commencing soon.

Glaucoma remains a leading cause of blindness worldwide, affecting over 70 million people


Dr Daemon McClunan, Founder

mobile: +27 (0)84 604 7600

location: Cape Town, South Africa

© 2017 Copyright reserved. Online Solutions by